03/29/23 7:00 AMNasdaq : TELA low floatTELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutionsRHEA-AIneutral
03/23/23 7:00 AMNasdaq : TELA low floatTELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive SurgeryTELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimizeRHEA-AIvery positive
03/21/23 4:02 PMNasdaq : TELA earningslow floatTELA Bio Reports Fourth Quarter and Full Year 2022 Financial ResultsTELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's ownRHEA-AIneutral
03/16/23 7:00 AMNasdaq : TELA clinical triallow floatTELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia IndicationsTELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providingRHEA-AIneutral
02/28/23 7:00 AMNasdaq : TELA earningslow floatTELA Bio to Announce Fourth Quarter and Full Year 2022 Financial ResultsTELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of theRHEA-AIneutral
02/24/23 4:02 PMNasdaq : TELA low floatTELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of theRHEA-AIvery positive
02/21/23 7:00 AMNasdaq : TELA low floatTELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic TechniquesTELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes byRHEA-AIvery positive
02/14/23 7:00 AMNasdaq : TELA low floatTELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing OrganizationTELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announcedRHEA-AIvery positive
01/20/23 4:05 PMNasdaq : TELA low floatTELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of theRHEA-AIvery positive
01/09/23 7:00 AMNasdaq : TELA low floatTELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical WoundsTELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies thatRHEA-AIneutral